Pancreatic Cancer Research

ResearcherUniversity of ArizonaNo recent work listed

Ivo L Abraham

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-0490-4421; OpenAlex author ID A5108727792. Sources: OpenAlex.

Their work

Papers
4 (first author 0, last author 4)
Trials
0
Grants
0
Labs led
1
Collaborators
6
Papers, trials and grants by year

2018: 2 papers · 2019: none · 2020: 1 paper · 2021: 1 paper

Papers 4

  1. Conversion to biosimilar pegfilgrastim-cbqv enables budget-neutral access to FOLFIRINOX treatment for metastatic pancreatic cancer. Last author DOI 10.2217/fon-2021-0718↗
  2. Exposure to proton pump inhibitors and risk of pancreatic cancer: a meta-analysis. Last author DOI 10.1080/14740338.2020.1715939↗
  3. Economic Evaluation for USA of Systemic Chemotherapies as First-Line Treatment of Metastatic Pancreatic Cancer. Last author DOI 10.1007/s40273-018-0678-6↗
  4. Economic Evaluation for the UK of Systemic Chemotherapies as First-Line Treatment of Metastatic Pancreatic Cancer. Last author DOI 10.1007/s40273-018-0684-8↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Ali McBride · 4 shared papers, 2018–2021 · strength 0.48
  2. Karen MacDonald · 1 shared paper, 2021 · strength 0.19
  3. Mahdi Gharaibeh · 2 shared papers, 2018 · strength 0.17
  4. Nasser Alkhushaym · 1 shared paper, 2020 · strength 0.11
  5. Mok Oh · 1 shared paper, 2020 · strength 0.11
  6. Hani M. Babiker · 1 shared paper, 2020 · strength 0.11

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.